Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
Номер патента: EP1490695A1
Опубликовано: 29-12-2004
Автор(ы): Alessandra Moretti, Götz Münch, Hans-Peter Holthoff, Karl-Ludwig c/o ProCorde GmbH LAUGWITZ, Martin Ungerer
Принадлежит: Procorde Gmbh
Опубликовано: 29-12-2004
Автор(ы): Alessandra Moretti, Götz Münch, Hans-Peter Holthoff, Karl-Ludwig c/o ProCorde GmbH LAUGWITZ, Martin Ungerer
Принадлежит: Procorde Gmbh
Реферат: The invention discloses use of peptide containing an essential ventricular myosin light chain type 1 (vMLC1) amino acid sequence, which is functional as cleavage site for caspase-3, in the screening for a compound for the treatment of chronic or acute cardiovascular disease. Further, screening methods for inhibitors of the caspase-3-mediated cleavage of vMLC1 are disclosed.
Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
Номер патента: US20050233405A1. Автор: Martin Ungerer,Götz Münch,Hans-Peter Holthoff,Karl-Ludwig Laugwitz,Alessandra Moretti. Владелец: Procorde Gmbh. Дата публикации: 2005-10-20.